Global Information
회사소개 | 문의

세계의 Point of Care 검사(POCT) 시장 : 제품별(혈당 모니터링 키트, 혈액가스 및 전해질(BGE) 분석기, 임신 검사, 감염증 검사 등) 전망

Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022

리서치사 RNCOS E-Services Pvt. Ltd.
발행일 2018년 09월 상품 코드 409578
페이지 정보 영문 90 Pages
가격
US $ 1,500 ₩ 1,710,000 PDF by E-mail (Single User License)
US $ 1,700 ₩ 1,938,000 CD-ROM
US $ 1,700 ₩ 1,938,000 Hard Copy
US $ 2,500 ₩ 2,851,000 PDF by E-mail (Multi-User License)


세계의 Point of Care 검사(POCT) 시장 : 제품별(혈당 모니터링 키트, 혈액가스 및 전해질(BGE) 분석기, 임신 검사, 감염증 검사 등) 전망 Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022
발행일 : 2018년 09월 페이지 정보 : 영문 90 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 Point of Care 검사(POCT: Point of Care Testing) 관련 시장을 분석했으며, Point of Care 진단/검사 개요, 시장 전체 및 제품별·지역 동향 전망, 주요 시장 성장 촉진요인 및 억제요인, 주요 기업 개요와 경쟁 전략, 향후의 기술 개발 및 시장 성장 방향성 등에 대해 전해드립니다.

제1장 애널리스트의 견해

제2장 분석 방법

제3장 체외진단 시장 개요

  • 서론
  • 체외진단이란 무엇인가?
  • 시장 규모와 성장률

제4장 Point of Care 진단(POCD) : 개요

제5장 시장 역학

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회

제6장 Point of Care 검사(POCT) 시장 전망

제7장 POCT 시장 : 제품별

  • 서론
    • 혈당 모니터링 키트
    • 혈액가스 및 전해질 분석기
    • 임신 및 수정 검사 키트
    • 감염증 검사 키트
    • 기타

제8장 POCT 시장 : 지역별

  • 서론
    • 북미
    • 유럽
    • 아시아태평양 지역
    • 기타 국가(RoW)

제9장 업계 동향과 동정

  • 휴대식 초음파 장비에 의한 온사이트(현지)에서의 의료 제공
  • 마이크로유체 기술(Microfluidics Technology)의 POCT 산업 침투

제10장 기업 개요

LSH 17.02.15

Point-of-Care testing can be defined as the medical diagnostic testing performed outside the clinical laboratory near to the place where the patient is receiving treatment. This type of testing is performed by non-laboratory personnel and the results are used for clinical decision making. The Point-of-Care tests have immense potential to improve global health, and to eventually reduce public and national spending on health.

The Point-of-Care testing devices have now found applications in a large number of medical conditions. Due to its increased usage in the field of critical care settings to deliver decentralized, patient-centric healthcare to the patients, the projections for the global Point-of-Care testing market is expected to witness a rapid growth. It is predicted that by 2022, the global Point-of-Care testing market will reach U$$ 30 Billion.

As per RNCOS report "Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022", the global Point-of-Care testing market is anticipated to witness a rapid growth during 2017-2022. This report provides a detailed analysis of the current and future market scenario of the global Point-of-Care testing market with a brief outlook of the IVD industry. The report provides insight about the major drivers, such as increasing awareness about POCT, technological advancements, increasing FDA approvals, for the global Point-of-Care testing market.

Furthermore, few challenges, such as product recalls and lack of regulatory standards, hindering the growth of the global Point-of-Care testing market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Point-of-Care testing market. Various trends and developments in the industry have also been cited in the report.

The global Point-of-Care testing market has been segmented on the basis of type of product. The major types of Point-of-Care testing present in the market include glucose monitoring kits, blood gas and electrolyte analysers, pregnancy & fertility testing kits, cardiac markers, infectious diseases testing kits, coagulation monitoring kits and drug-of-abuse testing kits amongst others. According to the report, glucose monitoring kits accounted for the largest share in 2017 due to rising prevalence of diabetes & technological advancements in self-monitoring of blood glucose. Based on geography, the report divides the market into North America, Europe, Asia-Pacific, and Rest of the World. In 2017, North America accounted for the largest share.

The last section of the report discusses about the prominent players in global Point-of-Care testing market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios. The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Point-of-Care testing market.

Table of Contents

1. Analyst View

2. Research Methodology

3. In Vitro Diagnostic Market Overview

  • 3.1 Introduction
  • 3.2 What is In Vitro Diagnostics?
  • 3.3 Market Size and Growth

4. Point-of-Care Diagnostics: An Overview

5. Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Prevalence of Infectious and Lifestyle Related Diseases
    • 5.1.2 Rising Use of Home Based Point-of-Care Diagnostics
    • 5.1.3 Government Initiatives
    • 5.1.4 Technological Advancements
    • 5.1.5 Rising FDA Approvals
    • 5.1.6 Lack of Skilled Lab Personnel
    • 5.1.7 Rising Awareness about POCT
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
    • 5.2.2 Lack of Regulatory Standards
    • 5.2.3 Data Management & Connectivity
  • 5.3 Market Opportunities
    • 5.3.1 Physical Robotic Telepresence
    • 5.3.2 Smart Virtual Assistant in Association with Mobile Devices

6. Point-of-Care Testing Market Outlook 2022

7. Point-of-Care Testing Market, By Product

  • 7.1 Introduction
    • 7.1.1 Glucose Monitoring Kits
    • 7.1.2 Blood Gas and Electrolyte Analyzers
    • 7.1.3 Pregnancy & Fertility Testing Kits
    • 7.1.4 Cardiac Markers
    • 7.1.5 Infectious Diseases Testing Kits
    • 7.1.6 Drug-of-Abuse Testing Kits
    • 7.1.7 Others

8. Point-of-Care Testing Market, By Region

  • 8.1 Introduction
    • 8.1.1 North America
    • 8.1.2 Europe
    • 8.1.3 Asia Pacific
    • 8.1.4 Rest of the World

9. Industry Trends and Developments

  • 9.1 Portable Ultrasound Providing Care on Site
  • 9.2 Microfluidics Technology Crowding the POCT Industry

10. Company Profiles

  • 10.1 Becton, Dickinson and Company
  • 10.2 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
  • 10.3 Siemens Healthineers
  • 10.4 Danaher Corporation
  • 10.5 Abbott Laboratories
  • 10.6 Johnson & Johnson
  • 10.7 OraSure Technologies, Inc.
  • 10.8 Thermo Fisher Scientific Inc.
  • 10.9 Medtronic plc

List of Figures

  • Figure 3-1: Global - Diabetes Incidence (Million), 2015 & 2040
  • Figure 3-2: Global - In Vitro Diagnostic Market (Billion US$), 2017-2022
  • Figure 6-1: Global - Share of Point-of-Care Testing in the IVD Market (%), 2017
  • Figure 6-2: Global - Share of Point-of-Care Testing in the IVD Market (%), 2022
  • Figure 6-3: Global - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 7-1: Global - Point-of-Care Testing Market by Product (%), 2017
  • Figure 7-2: Global - Point-of-Care Testing Market by Product (%), 2022
  • Figure 7-3: Global - Glucose Monitoring Kits Market (Billion US$), 2017-2022
  • Figure 7-4: Global - Blood Gas and Electrolyte Analyzers Market (Billion US$), 2017-2022
  • Figure 7-5: Global - Pregnancy & Fertility Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-6: Global - Cardiac Markers Market (Billion US$), 2017-2022
  • Figure 7-7: Global - Infectious Diseases Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-8: Global - Drug-of-Abuse Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-9: Global - Other POC Testing Kits Market (Billion US$), 2017-2022
  • Figure 8-1: Global - Point-of-Care Testing Market by Region (%), 2017
  • Figure 8-2: Global - Point-of-Care Testing Market by Region (%), 2022
  • Figure 8-3: North America - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-4: Europe - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-5: Asia Pacific - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-6: Rest of the World - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 10-1: Becton, Dickinson and Company - Revenue by Segment (%), 2017
  • Figure 10-2: Becton, Dickinson and Company - Revenue by Geography (%), 2017
  • Figure 10-3: Roche Diagnostics - Revenue by Segment (%), 2017
  • Figure 10-4: Danaher Corporation - Revenue by Segment (%), 2017
  • Figure 10-5: Danaher Corporation - Revenue by Geography (%), 2017
  • Figure 10-6: Abbott Laboratories - Revenue by Segment (%), 2017
  • Figure 10-7: Abbott Laboratories - Revenue by Geography (%), 2017
  • Figure 10-8: Johnson & Johnson - Revenue by Segment (%), 2017
  • Figure 10-9: Johnson & Johnson - Medical Devices Revenue by Segment (%), 2017
  • Figure 10-10: Johnson & Johnson - Revenue by Geography (%), 2017
  • Figure 10-11: Johnson & Johnson - Medical Devices Revenue by Geography (%), 2017
  • Figure 10-12: OraSure Technologies, Inc. - Revenue by Segment (%), 2017
  • Figure 10-13: OraSure Technologies, Inc. - OSUR Revenue by Segment (%), 2017
  • Figure 10-14: OraSure Technologies, Inc. - Revenue by Geography (%), 2017
  • Figure 10-15: Thermo Fisher Scientific Inc. - Revenue by Segment (%), 2017
  • Figure 10-16: Thermo Fisher Scientific Inc. - Revenue by Geography (%), 2017
  • Figure 10-17: Medtronic plc - Revenue by Segment (%), 2017
  • Figure 10-18: Medtronic plc - Revenue by Geography (%), 2017

List of Tables

  • Table 7-1: Frequently used Point-of-Care Glucose Monitoring Devices
  • Table 7-2: Differences between the Blood Gas Analyzer and Auto-Analyzer
  • Table 7-3: Home Pregnancy Test Kits
  • Table 10-1: Becton, Dickinson and Company - Net Sales (Million US$), 2015-2017
  • Table 10-2: Becton, Dickinson and Company - Product Portfolio for Point-of-Care Testing
  • Table 10-3: Roche Diagnostics - Net Sales (Million US$), 2015-2017
  • Table 10-4: Roche Diagnostics - Product Portfolio for Point-of-Care Testing
  • Table 10-5: Siemens Healthineers - Net Sales (Million US$), 2015-2017
  • Table 10-6: Siemens Healthineers - Product Portfolio for Point-of-Care Testing
  • Table 10-7: Danaher Corporation - Net Sales (Million US$), 2015-2017
  • Table 10-8: Danaher Corporation - Product Portfolio for Point-of-Care Testing
  • Table 10-9: Abbott Laboratories - Net Sales (Million US$), 2015-2017
  • Table 10-10: Abbott Laboratories - Product Portfolio for Point-of-Care Testing
  • Table 10-11: Johnson & Johnson - Net Sales (Million US$), 2015-2017
  • Table 10-12: Johnson & Johnson - Product Portfolio for Point-of-Care Testing
  • Table 10-13: OraSure Technologies, Inc. - Net Sales (Million US$), 2015-2017
  • Table 10-14: OraSure Technologies, Inc. - Product Portfolio for Point-of-Care Testing
  • Table 10-15: Thermo Fisher Scientific Inc. - Net Sales (Million US$), 2015-2017
  • Table 10-16: Thermo Fisher Scientific Inc. - Product Portfolio for Point-of-Care Testing
  • Table 10-17: Medtronic plc - Net Sales (Million US$), 2015-2017
  • Table 10-18: Medtronic plc - Product Portfolio for Point-of-Care Testing
Back to Top
전화 문의
이용안내
 
BCC Research